Comparing two kinds of exercise in women with polycystic ovary syndrome
Compares interval training and mat Pilates for fitness and well-being in women with PCOS.
Plain-language title generated from the registry record
Registry title: High Intensity Interval Training Versus Mat Pilates in Women With PCOS
Key facts
- Where
- Islamabad, PakistanSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women aged 18 to 35 with polycystic ovary syndrome (PCOS) who are not very active. It compares two exercise programs with a control group.
- Age
- 18 to 35 years
- Sex
- Women only
- Disease stage
- Polycystic ovary syndrome (PCOS) diagnosed by the Rotterdam Criteria
- Earlier treatment
- People currently on a structured exercise program or hormonal therapy cannot join.
Main reasons for not taking part
- Pregnancy or planning pregnancy
- Diagnosed endocrine disorders, such as thyroid disorders or Cushing syndrome
- Diagnosed cardiovascular, musculoskeletal or metabolic diseases
- Recent pelvic or abdominal surgery
- Currently on a structured exercise program or hormonal therapy
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 35 years old?
Source: NCT07875400, who can take part
Where in Pakistan
- Riphah International UniversityIslamabad, PakistanContact: Dr.Aneeqa Farooq, MSPTNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Riphah International University
- Trial code
- NCT07875400
- Record updated
- 15 October 2026
- Original description
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age and is associated with obesity, insulin resistance, poor physical fitness, and reduced quality of life. This randomized controlled trial will examine how High intensity Interval Training (HIIT) and Mat Pilates effect body composition, physical fitness, and quality of life in women diagnosed with Polycystic Ovary Syndrome (PCOS) . A total of 60 participants will be randomly assigned to one of three groups; HIIT, Mat Pilates, or a control group. Each intervention will run for eight weeks, with body composition, physical fitness, and quality of life measured both before and after the program to evaluate the comparative effectiveness of the two exercise intervention.Read full original descriptionShow less
Effects of High Intensity Interval Training Versus Mat Pilates on Body Composition, Physical Fitness and Quality of Life in Women With Poly Cystic Ovarian Syndrome
Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age and is associated with obesity, insulin resistance, poor physical fitness, and reduced quality of life. This randomized controlled trial will examine how High intensity Interval Training (HIIT) and Mat Pilates effect body composition, physical fitness, and quality of life in women diagnosed with Polycystic Ovary Syndrome (PCOS) . A total of 60 participants will be randomly assigned to one of three groups; HIIT, Mat Pilates, or a control group. Each intervention will run for eight weeks, with body composition, physical fitness, and quality of life measured both before and after the program to evaluate the comparative effectiveness of the two exercise intervention.
Inclusion: Women diagnosed with Polycystic Ovary Syndrome (PCOS) as per Rotterdam Criteria; Sedentary or low physical activity level; Willing to participate and provide informed consent.
Exclusion: Recent pelvic or abdominal surgery; Currently on structured exercise program or hormonal therapy; Diagnosed endocrine disorders (e.g., thyroid disorders, Cushing syndrome); Diagnosed cardiovascular, musculoskeletal, or metabolic diseases; Pregnancy or planning pregnancy.